Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 372 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: 10/18/21
End: 05/07/23
Due: 05/07/24
Phase: N/A
Priority: Normal
Start: 02/21/20
End: 02/01/27
Due: 02/01/28
Phase: N/A
Priority: Normal
Start: 07/08/19
End: 01/11/27
Due: 01/11/28
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 06/04/15
End: 06/17/19
Due: 06/17/20
Phase: N/A
Priority: Normal
Start: 06/30/03
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 09/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/04
End: 11/27/17
Due: 11/27/18
Phase: N/A
Priority: Normal
Start: 12/12/16
End: 06/18/21
Due: 06/18/22
Phase: N/A
Priority: Normal
Start: 08/31/03
End: -
Due: -
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Phase: N/A
Priority: Normal
Start: 12/01/08
End: 01/17/18
Due: 01/17/19
Phase: N/A
Priority: Normal
Start: 01/30/18
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 10/13/21
End: 03/13/23
Due: 03/13/24
Phase: N/A
Priority: Normal
Start: 04/27/21
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 10/25/24
End: 12/16/29
Due: 12/16/30
Phase: N/A
Priority: Normal
Start: 08/26/13
End: 06/16/17
Due: 06/16/18
Phase: N/A
Priority: Normal
Start: 05/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/99
End: 02/28/05
Due: 02/28/06
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 06/17/25
End: 06/17/28
Due: 06/17/29
Phase: N/A
Priority: Normal
Start: 12/01/25
End: 06/01/29
Due: 06/01/30
Phase: N/A
Priority: Normal
Start: 01/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/12/20
End: 04/01/27
Due: 04/01/28
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 05/25/21
Due: 05/25/22